Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

Águeda Molinos-Quintana; Anna Alonso-Saladrigues; Blanca Herrero; Teresa Caballero-Velázquez; Víctor Galán-Gómez; Melissa Panesso; Montserrat Torrebadell; Javier Delgado-Serrano; Concepción Pérez de Soto; Anna Faura; Berta González-Martínez; Ana Castillo-Robleda; Cristina Diaz-de-Heredia; Antonio Pérez-Martínez; José María Pérez-Hurtado; Susana Rives; José Antonio Pérez-Simón

doi:10.3389/fimmu.2024.1373852

Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

Front Immunol. 2024 Feb 7:15:1373852. doi: 10.3389/fimmu.2024.1373852. eCollection 2024.

Authors

Águeda Molinos-Quintana¹, Anna Alonso-Saladrigues², Blanca Herrero³, Teresa Caballero-Velázquez⁴, Víctor Galán-Gómez⁵, Melissa Panesso⁶, Montserrat Torrebadell², Javier Delgado-Serrano⁴, Concepción Pérez de Soto¹, Anna Faura², Berta González-Martínez⁵, Ana Castillo-Robleda³, Cristina Diaz-de-Heredia⁶, Antonio Pérez-Martínez⁵, José María Pérez-Hurtado¹, Susana Rives^{7

8}, José Antonio Pérez-Simón⁴

Affiliations

¹ Pediatric Unit, Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.
² CAR T-cell Unit. Leukemia and Lymphoma Department. Pediatric Cancer Center Barcelona (PCCB). Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain.
³ Pediatric Hemato-Oncology Department, Peditric University Hospital del Niño Jesús, Madrid, Spain.
⁴ Department of Hematology, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.
⁵ Pediatric Hemato-Oncology Department, University Hospital La Paz, Institute for Health Research (IdiPAZ), Universidad Autónoma de Madrid, Madrid, Spain.
⁶ Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
⁷ Pediatric Cancer Center Barcelona (PCCB), Institut de Recerca Sant Joan de Déu, Leukemia and Pediatric Hematology Disorders, Developmental Tumors Biology Group, Barcelona, Spain.
⁸ Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red De Enfermedades Raras (CIBERER), Madrid, Spain.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1280580.].

Keywords: B cell aplasia; B-cell monitoring; CD19 CART-cells; late B-cell recovery; pre-infusion tumor burden; relapsed/refractory acute lymphoblastic leukemia; tisagenlecleucel.

Copyright © 2024 Molinos-Quintana, Alonso-Saladrigues, Herrero, Caballero-Velázquez, Galán-Gómez, Panesso, Torrebadell, Delgado-Serrano, Pérez de Soto, Faura, González-Martínez, Castillo-Robleda, Diaz-de-Heredia, Pérez-Martínez, Pérez-Hurtado, Rives and Pérez-Simón.

Publication types

Published Erratum